164 related articles for article (PubMed ID: 33894563)
1. Mapping protein-protein interactions in homodimeric CYP102A1 by crosslinking and mass spectrometry.
Felker D; Zhang H; Bo Z; Lau M; Morishima Y; Schnell S; Osawa Y
Biophys Chem; 2021 Jul; 274():106590. PubMed ID: 33894563
[TBL] [Abstract][Full Text] [Related]
2. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.
Su M; Chakraborty S; Osawa Y; Zhang H
J Biol Chem; 2020 Feb; 295(6):1637-1645. PubMed ID: 31901079
[TBL] [Abstract][Full Text] [Related]
4. Mapping interactions of calmodulin and neuronal NO synthase by crosslinking and mass spectrometry.
Felker D; Lee K; Pospiech TH; Morishima Y; Zhang H; Lau M; Southworth DR; Osawa Y
J Biol Chem; 2024 Jan; 300(1):105464. PubMed ID: 37979917
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches.
Jeffreys LN; Pacholarz KJ; Johannissen LO; Girvan HM; Barran PE; Voice MW; Munro AW
J Biol Chem; 2020 May; 295(22):7595-7607. PubMed ID: 32303637
[TBL] [Abstract][Full Text] [Related]
7. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
Chen CK; Berry RE; Shokhireva TKh; Murataliev MB; Zhang H; Walker FA
J Biol Inorg Chem; 2010 Feb; 15(2):159-74. PubMed ID: 19727859
[TBL] [Abstract][Full Text] [Related]
8. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.
Chen CK; Shokhireva TKh; Berry RE; Zhang H; Walker FA
J Biol Inorg Chem; 2008 Jun; 13(5):813-24. PubMed ID: 18392864
[TBL] [Abstract][Full Text] [Related]
9. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
10. A highly active single-mutation variant of P450BM3 (CYP102A1).
Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
[TBL] [Abstract][Full Text] [Related]
11. Dimer Stabilization by SpyTag/SpyCatcher Coupling of the Reductase Domains of a Chimeric P450 BM3 Monooxygenase from Bacillus spp. Improves its Stability, Activity, and Purification.
Essert A; Castiglione K
Chembiochem; 2024 Feb; 25(3):e202300650. PubMed ID: 37994193
[TBL] [Abstract][Full Text] [Related]
12. Photooxidation of cytochrome P450-BM3.
Ener ME; Lee YT; Winkler JR; Gray HB; Cheruzel L
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18783-6. PubMed ID: 20947800
[TBL] [Abstract][Full Text] [Related]
13. Determination of HER2 binding domain in antigen-antibody complexes based on chemical crosslinking mass spectrometry.
Wang L; Xie L; Zhang Z
J Proteomics; 2023 Aug; 286():104954. PubMed ID: 37390893
[TBL] [Abstract][Full Text] [Related]
14. [Atomic force microscopy visualization and measurement of the activity and physicochemical properties of single monomeric and oligomeric enzymes].
Ivanov IuD; Bukharina NS; Pleshakova TO; Frantsuzov PA; Krokhin NV; Ziborov VS; Archakov AI
Biofizika; 2011; 56(5):939-44. PubMed ID: 22117449
[TBL] [Abstract][Full Text] [Related]
15. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
16. [Oligomeric state investigation of flavocytochrome CYP102A1 using AFM with standard and supersharp probes].
Ivanov IuD; Bukharina NS; Frantsuzov PA; Krokhin NV; Kanashenko SL; Archakov AI
Biomed Khim; 2013; 59(4):378-87. PubMed ID: 24502136
[TBL] [Abstract][Full Text] [Related]
17. [Electrochemical measurement of intraprorein and interprotein electron transfer].
Shumiantseva VV; Bulko TV; Lisitsina VB; Urlakher VB; Kuzikov AB; Suprun EV; Archakov AI
Biofizika; 2013; 58(3):453-60. PubMed ID: 24159813
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
[TBL] [Abstract][Full Text] [Related]
19. Cross-linked cytochrome P450 BM3 aggregates promoted by Ru(II)-diimine complexes bearing aldehyde groups.
Do MQ; Henry E; Kato M; Cheruzel L
J Inorg Biochem; 2018 Sep; 186():130-134. PubMed ID: 29890400
[TBL] [Abstract][Full Text] [Related]
20. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
